Skip to content
1887

Abstract

The COVID-19 pandemic has necessitated the rapid development and implementation of whole-genome sequencing (WGS) and bioinformatic methods for managing the pandemic. However, variability in methods and capabilities between laboratories has posed challenges in ensuring data accuracy. A national working group comprising 18 laboratory scientists and bioinformaticians from Australia and New Zealand was formed to improve data concordance across public health laboratories (PHLs). One effort, presented in this study, sought to understand the impact of the methodology on consensus genome concordance and interpretation. SARS-CoV-2 WGS proficiency testing programme (PTP) data were retrospectively obtained from the 2021 Royal College of Pathologists of Australasia Quality Assurance Programmes (RCPAQAP), which included 11 participating Australian laboratories. The submitted consensus genomes and reads from eight contrived specimens were investigated, focusing on discordant sequence data and findings were presented to the working group to inform best practices. Despite using a variety of laboratory and bioinformatic methods for SARS-CoV-2 WGS, participants largely produced concordant genomes. Two participants returned five discordant sites in a high-Cτ replicate, which could be resolved with reasonable bioinformatic quality thresholds. We noted ten discrepancies in genome assessment that arose from nucleotide heterogeneity at three different sites in three cell-culture-derived control specimens. While these sites were ultimately accurate after considering the participants’ bioinformatic parameters, it presented an interesting challenge for developing standards to account for intrahost single nucleotide variation (iSNV). Observed differences had little to no impact on key surveillance metrics, lineage assignment and phylogenetic clustering, while genome coverage <90 % affected both. We recommend PHLs bioinformatically generate two consensus genomes with and without ambiguity thresholds for quality control and downstream analysis, respectively, and adhere to a minimum 90 % genome coverage threshold for inclusion in surveillance interpretations. We also suggest additional PTP assessment criteria, including primer efficiency, detection of iSNVs and minimum genome coverage of 90 %. This study underscores the importance of multidisciplinary national working groups in informing guidelines in real time for bioinformatic quality acceptance criteria. It demonstrates the potential for enhancing public health responses through improved data concordance and quality control in SARS-CoV-2 genomic analysis during pandemic surveillance.

Funding
This study was supported by the:
  • National Health and Medical Research Council (Award MRF9200006)
    • Principle Award Recipient: WilliamD. Rawlinson
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001146
2023-11-29
2025-02-15
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/11/mgen001146.html?itemId=/content/journal/mgen/10.1099/mgen.0.001146&mimeType=html&fmt=ahah

References

  1. Chen Z, Azman AS, Chen X, Zou J, Tian Y et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat Genet 2022; 54:499–507 [View Article] [PubMed]
    [Google Scholar]
  2. Lane CR, Sherry NL, Porter AF, Duchene S, Horan K et al. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study. Lancet Public Health 2021; 6:e547–e556 [View Article] [PubMed]
    [Google Scholar]
  3. Issues with SARS-Cov-2 sequencing data. Virological; 2020 https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473 accessed 15 November 2022
  4. Freed NE, Vlková M, Faisal MB, Silander OK. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore rapid barcoding. Biol Methods Protoc 2020; 5:bpaa014 [View Article] [PubMed]
    [Google Scholar]
  5. Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc 2017; 12:1261–1276 [View Article] [PubMed]
    [Google Scholar]
  6. Foster CSP, Stelzer-Braid S, Deveson IW, Bull RA, Yeang M et al. Assessment of inter-laboratory differences in SARS-CoV-2 consensus genome assemblies between Public Health Laboratories in Australia. Viruses 2022; 12:16194 [View Article] [PubMed]
    [Google Scholar]
  7. Liu T, Chen Z, Chen W, Chen X, Hosseini M et al. A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples. iScience 2021; 24:102892 [View Article] [PubMed]
    [Google Scholar]
  8. Xiaoli L, Hagey JV, Park DJ, Gulvik CA, Young EL et al. Benchmark datasets 507 for SARS-CoV-2 surveillance bioinformatics. PeerJ 2022; 10:e13821 [View Article] [PubMed]
    [Google Scholar]
  9. Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 2020; 5:1403–1407 [View Article] [PubMed]
    [Google Scholar]
  10. Frampton D, Rampling T, Cross A, Bailey H, Heaney J et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis 2021; 21:1246–1256 [View Article] [PubMed]
    [Google Scholar]
  11. Geoghegan JL, Ren X, Storey M, Hadfield J, Jelley L et al. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand. Nat Commun 2020; 11:6351 [View Article] [PubMed]
    [Google Scholar]
  12. Hoang T, da Silva AG, Jennison AV, Williamson DA, Howden BP et al. AusTrakka: fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic. Nat Commun 2022; 13:865 [View Article] [PubMed]
    [Google Scholar]
  13. Lau KA, Horan K, Gonçalves da Silva A, Kaufer A, Theis T et al. Proficiency testing for SARS-CoV-2 whole genome sequencing. Pathology 2022; 54:615–622 [View Article] [PubMed]
    [Google Scholar]
  14. Lemoine F, Gascuel O. Gotree/Goalign: toolkit and Go API to facilitate the development of phylogenetic workflows. NAR Genom Bioinform 2021; 3:lqab075 [View Article] [PubMed]
    [Google Scholar]
  15. Quick J. nCoV-2019 sequencing protocol V3 (Locost). protocols 2019
    [Google Scholar]
  16. Tyson JR, James P, Stoddart D, Sparks N, Wickenhagen A et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 2020 [View Article] [PubMed]
    [Google Scholar]
  17. Freed N, Silander O. SARS-CoV2 genome sequencing protocol (1200bp amplicon “midnight” primer set, using Nanopore Rapid kit). protocols 2021 [View Article]
    [Google Scholar]
  18. Eden J-S, Rockett R, Carter I, Rahman H, de Ligt J et al. An emergent clade of SARS-CoV-2 linked to returned travellers from Iran. Virus Evol 2020; 6:veaa027 [View Article] [PubMed]
    [Google Scholar]
  19. Eden J-S, Sim E. SARS-CoV-2 genome sequencing using long pooled amplicons on illumina platforms v1. protocols [View Article] [PubMed]
    [Google Scholar]
  20. O’Toole Á, Scher E, Underwood A, Jackson B, Hill V et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol 2021; 7:veab064 [View Article] [PubMed]
    [Google Scholar]
  21. Aiewsakun P, Phumiphanjarphak W, Ludowyke N, Purwono PB, Manopwisedjaroen S et al. Systematic exploration of SARS-CoV-2 adaptation to vero E6, vero E6/TMPRSS2, and calu-3 cells. Genome Biol Evol 2023; 15:evad035 [View Article] [PubMed]
    [Google Scholar]
  22. Lau KA, Gonçalves da Silva A, Theis T, Gray J, Ballard SA et al. Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories. Pathology 2021; 53:902–911 [View Article] [PubMed]
    [Google Scholar]
  23. Moran-Gilad J, Sintchenko V, Pedersen SK, Wolfgang WJ, Pettengill J et al. Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities. BMC Infect Dis 2015; 15:174 [View Article] [PubMed]
    [Google Scholar]
  24. Gargis AS, Kalman L, Lubin IM, Kraft CS. Assuring the quality of next-generation sequencing in clinical microbiology and public health laboratories. J Clin Microbiol 2016; 54:2857–2865 [View Article] [PubMed]
    [Google Scholar]
  25. Borcard L, Gempeler S, Terrazos Miani MA, Baumann C, Grädel C et al. Investigating the extent of primer dropout in SARS-CoV-2 genome sequences during the early circulation of delta variants. FrontVirol 2020; 2: [View Article]
    [Google Scholar]
  26. Lambisia AW, Mohammed KS, Makori TO, Ndwiga L, Mburu MW et al. Optimization of the SARS-CoV-2 ARTIC network V4 primers and whole genome sequencing protocol. Front Med 2022; 9:836728 [View Article] [PubMed]
    [Google Scholar]
  27. Cotten M, Lule Bugembe D, Kaleebu P, Phan TMV. Alternate primers for whole-genome SARS-CoV-2 sequencing. Virus Evol 2021; 7:veab006 [View Article] [PubMed]
    [Google Scholar]
  28. Armero A, Berthet N, Avarre J-C. Intra-host diversity of SARS-Cov-2 should not be neglected: case of the state of Victoria, Australia. Viruses 2021; 13:133 [View Article] [PubMed]
    [Google Scholar]
  29. Lythgoe KA, Hall M, Ferretti L, de Cesare M, MacIntyre-Cockett G et al. SARS-CoV-2 within-host diversity and transmission. Science 2021; 372:eabg0821 [View Article] [PubMed]
    [Google Scholar]
  30. Davis JJ, Long SW, Christensen PA, Olsen RJ, Olson R et al. Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein. Microbiol Spectr 2021; 9:e0180321 [View Article] [PubMed]
    [Google Scholar]
  31. Bei Y, Pinet K, Vrtis KB, Borgaro JG, Sun L et al. Overcoming variant mutation-related impacts on viral sequencing and detection methodologies. Front Med 2022; 9: [View Article] [PubMed]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001146
Loading
/content/journal/mgen/10.1099/mgen.0.001146
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error